References
- Enserink M. France. Sarkozy’s ‘Grand Loan’ bets that research will pay off. Science 2009; 326:1613; http://dx.doi.org/10.1126/science.326.5960.1613-a; PMID: 20019265
- Laboratoire d’excellence MAbImprove. http://mabimprove.univ-tours.fr/?lang=en
- Watiez D, Watier H. [Therapeutic monoclonal antibodies in the French community: let’s get organized]. Med Sci (Paris) 2009; 25:1189 - 92; http://www.gdraccith.fr/index.php?page=en http://dx.doi.org/10.1051/medsci/200925121189; PMID: 20035704
- Institut de Recherche en Cancérologie de Montpellier http://www.ircm.fr/index.php?locale=en
- Lefranc MP. Antibody nomenclature: from IMGT-ONTOLOGY to INN definition. MAbs 2011; 3:1 - 2; http://www.imgt.org/ http://dx.doi.org/10.4161/mabs.3.1.14151; PMID: 21099347
- Daguet A, Watier H. 2nd Charles Richet et Jules Héricourt workshop: therapeutic antibodies and anaphylaxis; May 31-June 1, 2011, Tours, France. MAbs 2011; 3:417 - 21; http://dx.doi.org/10.4161/mabs.3.5.17485; PMID: 21857165
- Desoubeaux G, Daguet A, Watier H. Therapeutic antibodies and infectious diseases, Tours, France, November 20-22, 2012. MAbs 2013; 5:626 - 32; http://taid.fr/?lang=en http://dx.doi.org/10.4161/mabs.25300; PMID: 23883703
- Guillon-Munos A, Daguet A, Watier H. Antibody biosimilars; Fears or opportunities? First LabEx MAbImprove industrial workshop, May 28, 2013; Tours, France. MAbs 2014; 6; In press http://dx.doi.org/10.4161/mabs.28831; PMID: 24714167
- Second LabEx MAbImprove industrial workshop: MabDosing. http://www.mabdosing.fr/en/index.html
- Institut du Cancer de Montpellier. . http://www.icm.unicancer.fr/fr
- SIRIC Montpellier Cancer http://montpellier-cancer.com/en/